337 related items for PubMed ID: 14586717
1. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[Abstract] [Full Text] [Related]
2. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[Abstract] [Full Text] [Related]
3. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[Abstract] [Full Text] [Related]
4. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy.
Shimizu A, Takei T, Uchida K, Tsuchiya K, Nitta K.
Nephrology (Carlton); 2009 Aug; 14(5):521-6. PubMed ID: 19674320
[Abstract] [Full Text] [Related]
5. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[Abstract] [Full Text] [Related]
6. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW, Fluck RJ, Lambie SH.
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[Abstract] [Full Text] [Related]
7. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.
Kennoki T, Ishida H, Yamaguchi Y, Tanabe K.
Transplantation; 2009 Oct 15; 88(7):935-41. PubMed ID: 19935466
[Abstract] [Full Text] [Related]
8. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
Medicina (B Aires); 2007 Oct 15; 67(5):445-50. PubMed ID: 18051227
[Abstract] [Full Text] [Related]
9. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
Singapore Med J; 2008 Nov 15; 49(11):924-9. PubMed ID: 19037561
[Abstract] [Full Text] [Related]
10. Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0 g/day.
Suzuki T, Yamamoto T, Ohura M, Fujigaki Y, Yonemura K, Kimura M, Hishida A.
Clin Exp Nephrol; 2004 Sep 15; 8(3):243-9. PubMed ID: 15480902
[Abstract] [Full Text] [Related]
11. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
Lai KN, Ho CP, Chan KW, Yan KW, Lai FM, Vallance-Owen J.
Q J Med; 1985 Oct 15; 57(222):677-88. PubMed ID: 4080957
[Abstract] [Full Text] [Related]
12. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group.
Am J Kidney Dis; 2006 May 15; 47(5):751-60. PubMed ID: 16632013
[Abstract] [Full Text] [Related]
13. Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria.
Suzuki S, Joh K.
Clin Exp Nephrol; 2004 Jun 15; 8(2):109-16. PubMed ID: 15235927
[Abstract] [Full Text] [Related]
14. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
Tsuruya K, Harada A, Hirakata H, Mitsuiki K, Johko T, Kondoh H, Takechi S, Fujishima M.
Clin Nephrol; 2000 Jan 15; 53(1):1-9. PubMed ID: 10661476
[Abstract] [Full Text] [Related]
15. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, Li LS.
Ren Fail; 2008 Jan 15; 30(6):611-6. PubMed ID: 18661411
[Abstract] [Full Text] [Related]
16. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
Kanno Y, Witt M, Okada H, Nemoto H, Sugahara S, Nakamoto H, Suzuki H.
Clin Exp Nephrol; 2003 Mar 15; 7(1):48-51. PubMed ID: 14586743
[Abstract] [Full Text] [Related]
17. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
J Nephrol; 2009 Mar 15; 22(3):387-96. PubMed ID: 19557716
[Abstract] [Full Text] [Related]
18. [Effects of steroid therapy in IgA nephropathy].
Ohashi T, Shimokawahara H, Fukumoto M, Azuma K, Uchida Y, Tokuda Y, Ito H, Yasumoto Y, Yamashita W, Harada R.
Fukuoka Igaku Zasshi; 1992 May 15; 83(5):209-15. PubMed ID: 1612550
[Abstract] [Full Text] [Related]
19. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T, Nakao H.
Ren Fail; 2005 May 15; 27(1):45-52. PubMed ID: 15717634
[Abstract] [Full Text] [Related]
20. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T, Amemiya N, Ochi A, Tsuruta Y, Shimizu A, Itabashi M, Takei T, Uchida K, Nitta K.
Am J Nephrol; 2011 May 15; 34(3):233-40. PubMed ID: 21778707
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
